UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 693

Sortiert nach

OECD validation of the rodent Hershberger assay using three reference chemicals; 17α-methyltestosterone, procymidone, and p, p'-DDE

Archives of toxicology, 2007-05, Vol.81 (5), p.309-318

2007

Volltextzugriff (PDF)

OECD validation of the rodent Hershberger assay using three reference chemicals; 17alpha-methyltestosterone, procymidone, and p,p'-DDE

Archives of toxicology, 2007-05, Vol.81 (5), p.309

2007

Volltextzugriff (PDF)

Intravascular ultrasound assessment of very late bare-metal stent thrombosis： a case report

Chinese medical journal, 2012-05, Vol.125 (9), p.1658-1660

2012

Volltextzugriff (PDF)

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1540-1550

2016

Volltextzugriff (PDF)

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

The lancet oncology, 2020-03, Vol.21 (3), p.373-386

2020

Volltextzugriff (PDF)

Historic and futuristic review of electron beam technology for the treatment of SO2 and NOx in flue gas

Chemical engineering journal (Lausanne, Switzerland : 1996), 2019-01, Vol.355, p.351-366

2019

Volltextzugriff (PDF)

Interlayer orientation-dependent light absorption and emission in monolayer semiconductor stacks

Nature communications, 2015-06, Vol.6 (1), p.7372-7372, Article 7372

2015

Volltextzugriff (PDF)

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603

2020

Volltextzugriff (PDF)

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

Journal of clinical oncology, 2012-04, Vol.30 (10), p.1122-1128

2012

Volltextzugriff (PDF)

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial

Journal of thoracic oncology, 2021-12, Vol.16 (12), p.2091-2108

2021

Volltextzugriff (PDF)

Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression

PloS one, 2011-07, Vol.6 (7), p.e22544

2011

Volltextzugriff (PDF)

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

The lancet oncology, 2019-12, Vol.20 (12), p.1681-1690

2019

Volltextzugriff (PDF)

CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice

Scientific reports, 2021-04, Vol.11 (1), p.7397-7397, Article 7397

2021

Volltextzugriff (PDF)

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2702-2709

2018

Volltextzugriff (PDF)

Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System

Hepatology (Baltimore, Md.), 2018-12, Vol.68 (6), p.2254-2266

2018

Volltextzugriff (PDF)

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

Nature communications, 2023-02, Vol.14 (1), p.1071-1071, Article 1071

2023

Volltextzugriff (PDF)

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-11, Vol.379 (21), p.2027-2039

2018

Volltextzugriff (PDF)

Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination Survey

Scientific reports, 2020-03, Vol.10 (1), p.3805, Article 3805

2020

Volltextzugriff (PDF)

Biological monitoring for exposure assessment of volatile organic compounds by Korean firefighters at the fire site

Industrial Health, 2021/11/01, Vol.60(5), pp.475-484

2021

Volltextzugriff (PDF)

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

The New England journal of medicine, 2017-02, Vol.376 (7), p.629-640

2017

Volltextzugriff (PDF)

Lego‐Like Model Reconfigurable and Transparent Stretchable Strain Sensor for Wearable and Biomedical Applications

Advanced functional materials, 2024-01, Vol.34 (3)

2024

Volltextzugriff (PDF)

Disseminated tuberculosis following adalimumab treatment in psoriasis despite negative screening

International journal of dermatology, 2019-01, Vol.58 (1), p.98-100

2019

Volltextzugriff (PDF)

Massively synthesizable nickel-doped 1T-MoS2 nanosheet catalyst as an efficient tri-functional catalyst

RSC advances, 2023-06, Vol.13 (26), p.18122-18127

2023

Volltextzugriff (PDF)

Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging

European radiology, 2018-06, Vol.28 (6), p.2549-2560

2018

Volltextzugriff (PDF)

1 – 25 von 693

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(612)
Mit Volltextzugriff
(668)

Publikationsform

Sprache

Englisch
(584)
Koreanisch
(100)
Japanisch
(73)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(410)
Life Sciences & Biomedicine
(343)
Humans
(200)
Female
(135)
Male
(128)
Middle Aged
(89)
Adult
(73)
Oncology
(66)
Aged
(65)
Original
(57)
Animals
(53)
Physical Sciences
(46)
Science & Technology - Other Topics
(42)
Patients
(40)
Chemistry
(39)
Medicine
(39)
Mice
(39)
Retrospective Studies
(37)
Mutation
(36)
Dermatology
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

OECD validation of the rodent Hershberger assay using three reference chemicals; 17α-methyltestosterone, procymidone, and p, p'-DDE

OECD validation of the rodent Hershberger assay using three reference chemicals; 17alpha-methyltestosterone, procymidone, and p,p'-DDE

Intravascular ultrasound assessment of very late bare-metal stent thrombosis： a case report

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Historic and futuristic review of electron beam technology for the treatment of SO2 and NOx in flue gas

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer

Interlayer orientation-dependent light absorption and emission in monolayer semiconductor stacks

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial

Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination Survey

Biological monitoring for exposure assessment of volatile organic compounds by Korean firefighters at the fire site

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

Lego‐Like Model Reconfigurable and Transparent Stretchable Strain Sensor for Wearable and Biomedical Applications

Disseminated tuberculosis following adalimumab treatment in psoriasis despite negative screening

Massively synthesizable nickel-doped 1T-MoS2 nanosheet catalyst as an efficient tri-functional catalyst

Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging

Suchergebnisse filtern